Tsvetelina P. Hoang

Tsvetelina P. Hoang is the Vice President of Research and Development at Marker Therapeutics. Tsvetelina has over 15 years of experience in the field of cancer research.

Hoang began their career as a Research Associate at Memorial Sloan-Kettering Cancer Center, where they worked for eight years. Tsvetelina then became an Instructor at MD Anderson Cancer Center, where they worked for two years. In 2015, they joined Bellicum Pharmaceuticals as a Senior Scientist. Tsvetelina was promoted to Director of Translational Research in 2018.

Hoang has a PhD in Molecular and Cell Biology from UC-Berkeley.

Dr. Tsvetelina P. Hoang has a PhD in Biology from The Johns Hopkins University and a BS/MS in MB&B from Yale University.

Some of their coworkers include Edmund Cheung - VP, Human Resources, Nadia Agopyan - SVP, Regulatory Affairs, and Neda Safarzadeh - Vice President/Head of Investor Relations, Public Relations & Marketing. Their manager is Peter L. Hoang, President & CEO.